Shukra [SHUKRAPHAR] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Shukra

BSE
Loading...

Divi's Laboratories

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Shukra wins in 5 metrics, Divi's Laboratories wins in 15 metrics, with 0 ties. Divi's Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricShukraDivi's LaboratoriesBetter
P/E Ratio (TTM)275.8565.37Divi's Laboratories
Price-to-Book Ratio25.6110.13Divi's Laboratories
Debt-to-Equity Ratio6.650.03Divi's Laboratories
PEG Ratio3.372.47Divi's Laboratories
EV/EBITDA100.3548.31Divi's Laboratories
Profit Margin (TTM)25.68%23.89%Shukra
Operating Margin (TTM)25.25%25.60%Divi's Laboratories
EBITDA Margin (TTM)25.25%25.60%Divi's Laboratories
Return on Equity15.24%14.64%Shukra
Return on Assets (TTM)11.04%12.94%Divi's Laboratories
Free Cash Flow (TTM)$51.75M$2.15BDivi's Laboratories
Dividend Yield3.20%0.91%Shukra
1-Year Return364.29%8.12%Shukra
Price-to-Sales Ratio (TTM)39.8515.71Divi's Laboratories
Enterprise Value$18.02B$1,480.60BDivi's Laboratories
EV/Revenue Ratio45.7415.34Divi's Laboratories
Gross Profit Margin (TTM)85.71%60.33%Shukra
Revenue per Share (TTM)$1$363Divi's Laboratories
Earnings per Share (Diluted)$0.13$87.36Divi's Laboratories
Beta (Stock Volatility)0.320.18Divi's Laboratories
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Shukra vs Divi's Laboratories Stock Performance Analysis

Loading Price Chart...

Shukra
Divi's Laboratories
Shukra Stock Overview | Divi's Laboratories Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Shukra-1.99%-0.09%23.88%107.66%67.40%140.74%
Divi's Laboratories2.73%3.10%-4.83%-14.69%1.79%-3.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Shukra364.29%579.49%2,326.06%2,066.67%828.57%828.57%
Divi's Laboratories8.12%57.02%83.89%435.51%1,516.65%7,132.15%

News Based Sentiment: Shukra vs Divi's Laboratories

Shukra

News based Sentiment: MIXED

September presented a mixed bag for Shukra Pharmaceuticals. While the company achieved a new 52-week high and secured a significant distribution partnership with Wockhardt, it also reported a substantial revenue contraction in FY25. The upcoming warrant issue adds another layer of complexity, making it a pivotal month for the company's future direction.

View Shukra News Sentiment Analysis

Divi's Laboratories

News based Sentiment: MIXED

September presented a mixed bag for Divi's Laboratories, with stellar FY25 results overshadowed by a weaker Q1 FY26 performance and fluctuating analyst opinions. The Nifty 50 exclusion adds another layer of complexity, creating a dynamic investment scenario that requires careful monitoring.

View Divi's Laboratories News Sentiment Analysis

Performance & Financial Health Analysis: Shukra vs Divi's Laboratories

MetricSHUKRAPHARDIVISLAB
Market Information
Market Cap i₹16.02B₹1.61T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i110,113437,716
90 Day Avg. Volume i340,504381,180
Last Close₹34.45₹5,866.00
52 Week Range₹5.75 - ₹35.86₹4,955.00 - ₹7,071.50
% from 52W High-3.93%-17.05%
All-Time High₹35.86 (Sep 30, 2025)₹7,071.50 (Jul 08, 2025)
% from All-Time High-3.93%-17.05%
Growth Metrics
Quarterly Revenue Growth0.67%0.14%
Quarterly Earnings Growth1.12%0.27%
Financial Health
Profit Margin (TTM) i0.26%0.24%
Operating Margin (TTM) i0.25%0.26%
Return on Equity (TTM) i0.15%0.15%
Debt to Equity (MRQ) i6.650.03
Cash & Liquidity
Book Value per Share (MRQ)₹1.40₹563.87
Cash per Share (MRQ)₹0.24₹132.86
Operating Cash Flow (TTM) i₹66.80M₹19.67B
Levered Free Cash Flow (TTM) i₹95.75M₹21.91B
Dividends
Last 12-Month Dividend Yield i3.20%0.91%
Last 12-Month Dividend i₹1.02₹60.00

Valuation & Enterprise Metrics Analysis: Shukra vs Divi's Laboratories

MetricSHUKRAPHARDIVISLAB
Price Ratios
P/E Ratio (TTM) i275.8565.37
Forward P/E iN/A101.43
PEG Ratio i3.372.47
Price to Sales (TTM) i39.8515.71
Price to Book (MRQ) i25.6110.13
Market Capitalization
Market Capitalization i₹16.02B₹1.61T
Enterprise Value i₹18.02B₹1.48T
Enterprise Value Metrics
Enterprise to Revenue i45.7415.34
Enterprise to EBITDA i100.3548.31
Risk & Other Metrics
Beta i0.320.18
Book Value per Share (MRQ) i₹1.40₹563.87

Financial Statements Comparison: Shukra vs Divi's Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SHUKRAPHARDIVISLAB
Revenue/Sales i₹53.91M₹24.10B
Cost of Goods Sold i₹7.70M₹9.56B
Gross Profit i₹46.21M₹14.54B
Research & Development iN/AN/A
Operating Income (EBIT) i₹5.32M₹6.17B
EBITDA i₹24.28M₹8.48B
Pre-Tax Income i₹13.73M₹7.33B
Income Tax i₹3.44M₹1.88B
Net Income (Profit) i₹10.30M₹5.45B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SHUKRAPHARDIVISLAB
Cash & Equivalents i₹121.18M₹4.15B
Total Current Assets i₹654.27M₹100.81B
Total Current Liabilities i₹172.84M₹14.52B
Long-Term Debt i₹31.13M₹20.00M
Total Shareholders Equity i₹628.36M₹149.69B
Retained Earnings i₹143.00M₹134.00B
Property, Plant & Equipment i₹193.97M₹3.19B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SHUKRAPHARDIVISLAB
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSHUKRAPHARDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i110,113437,716
Average Daily Volume (90 Day) i340,504381,180
Shares Outstanding i437.88M265.47M
Float Shares i54.95M120.77M
% Held by Insiders i0.89%0.52%
% Held by Institutions i0.00%0.29%

Dividend Analysis & Yield Comparison: Shukra vs Divi's Laboratories

MetricSHUKRAPHARDIVISLAB
Last 12-Month Dividend i₹1.02₹60.00
Last 12-Month Dividend Yield i3.20%0.91%
3-Year Avg Annual Dividend i₹0.35₹50.00
3-Year Avg Dividend Yield i3.91%0.70%
3-Year Total Dividends i₹1.05₹150.00
Ex-Dividend DateSep 23, 2025Jul 25, 2025